Antineoplastic and immunomodulating agents

Summary

The tender concerns medicines used in oncology treatment. It is a framework agreement for 48 months, under which medicines will be purchased according to actual needs and available budget; the exact quantity is not known at this stage. The framework agreement will be concluded with 2 economic operators, and subsequent orders will be placed as needed, expected roughly within 7 days after the framework agreement is signed. The machine-readable notice did not include the award criteria or precise participation requirements; these must be checked in the tender documents.